Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

GLEOSTINE

LOMUSTINE

Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Prescription
Summary

Approval overview GLEOSTINE is listed in Drugs@FDA under application 017588 (NDA).

Review priority: N/A Marketing status: Prescription Active ingredient LOMUSTINE Form and strength CAPSULE;ORAL - 10MG Sponsor AZURITY Submission history Latest submission status date: 2020-06-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview GLEOSTINE is listed in Drugs@FDA under application 017588 (NDA). Review priority: N/A Marketing status: Prescription Active ingredient LOMUSTINE Form and strength CAPSULE;ORAL - 10MG Sponsor AZURITY Submission history Latest submission status date: 2020-06-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: N/A

Interaction Notes

  • No interaction notes stored yet.
GLEOSTINE (LOMUSTINE) | Drug Monograph | MedicHelpline